Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Omaha Steve

(107,346 posts)
Sat Jun 10, 2023, 09:13 AM Jun 2023

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

Source: AP

By MATTHEW PERRONE today

WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early stages of the brain-robbing disease.

The drug, Leqembi, received conditional approval from the Food and Drug Administration in January based on early results suggesting it could slow Alzheimer’s progression by several months. The FDA now is reviewing more definitive results to decide whether the drug should receive the agency’s full endorsement.

The decision carries extra significance because insurers have held off on paying for the infused treatment until it has full FDA approval.

The FDA panel of outside advisers voted 6-0 that a large company study confirmed the drug’s benefits for patients with mild or early Alzheimer’s. The nonbinding vote amounts to a recommendation for full approval, and the FDA is scheduled to issue a final decision on the matter by July 6.




Read more: https://apnews.com/article/leqembi-alzheimers-drug-fda-f438cd0d1df98d1df0677a219cee6fa7

4 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use (Original Post) Omaha Steve Jun 2023 OP
Good news, with caveats... jmbar2 Jun 2023 #1
Anecdotally leighbythesea2 Jun 2023 #2
Wow, that's great news! SunSeeker Jun 2023 #3
Did they test it on trump? SouthernDem4ever Jun 2023 #4

jmbar2

(7,367 posts)
1. Good news, with caveats...
Sat Jun 10, 2023, 10:07 AM
Jun 2023
Leqembi is the first drug that’s been convincingly shown to slow Alzheimer’s by targeting the underlying biology of the disease. The delay in progression amounts to about five months..


The drug was also associated with potentially serious side effects, including swelling of the brain and small bleeds in brain vessels.


Estimated cost $26,000 year, which could potentially drive up Medicare costs significantly due to the number of seniors with the disease. Hopefully the government can do something to drive down these costs.

Not a huge leap, but every step forward offers hope.

leighbythesea2

(1,289 posts)
2. Anecdotally
Sat Jun 10, 2023, 10:30 AM
Jun 2023

I had a long conversation with someone whose father was in a trial for this drug, and got the drug they found out after. He had nearly zero decline in the 4 years. He was able to keep taking it after the trial, once it was revealed he had not been in placebo group. It was so encouraging to talk to her, bc my mom has Alzheimer’s. She’s past early stage, so could not take it now. But it’s heartening.

Latest Discussions»Latest Breaking News»Alzheimer's drug gets FDA...